GPT and obesity due to melanocortin 4 receptor deficiency: Guidelines from the Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN and ESPGHAN), recommend screening all children with obesity (age > 9 years old) for MASLD by testing alanine amino transaminase (ALT) levels, even though doing so has substantial limitations [10,11].